Finasteride: a review of its use in male pattern hair loss.

[1]  J. Shapiro,et al.  Finasteride in the treatment of men with androgenetic alopecia. Finasteride Male Pattern Hair Loss Study Group. , 1998, Journal of the American Academy of Dermatology.

[2]  R. Happle,et al.  Finasteride is the main inhibitor of 5α-reductase activity in dermal papillae of human hair follicles , 1998 .

[3]  M. V. Hansen,et al.  The urological management of men with lower urinary tract symptoms, recorded using an interactive computer program. , 1997, British journal of urology.

[4]  Ashok Sharma,et al.  Primary cutaneous inoculation blastomycosis with unusual features , 1997 .

[5]  C. Orfanos,et al.  The 5 alpha-reductase system and its inhibitors. Recent development and its perspective in treating androgen-dependent skin disorders. , 1996, Dermatology.

[6]  G. Tian.  In Vivo Time-Dependent Inhibition of Human Steroid 5a-Reductase by Finasteride , 1996 .

[7]  C. Orfanos,et al.  The 5α-Recluctase System and Its Inhibitors , 1996 .

[8]  N. Nikkels‐Tassoudji,et al.  Improvement in the inflammatory aspect of androgenetic alopecia. A pilot study with an antimicrobial lotion , 1996 .

[9]  M. Katz,et al.  Treatment of androgenetic alopecia with a 7.5% herbal preparation , 1996 .

[10]  T. Chen,et al.  FINASTERIDE INHIBITS 5α‐REDUCTASE ACTIVITY IN HUMAN DERMAL FIBROBLASTS: PREDICTION OF ITS THERAPEUTIC APPLICATION IN ANDROGEN‐RELATED SKIN DISEASES , 1995, International journal of dermatology.

[11]  R. Happle,et al.  Immunohistochemical evidence for differential distribution of 5α‐reductase isoenzymes in human skin , 1995, The British journal of dermatology.

[12]  D. Thiboutot,et al.  Activity of the type 1 5 alpha-reductase exhibits regional differences in isolated sebaceous glands and whole skin. , 1995, The Journal of investigative dermatology.

[13]  W. Bergfeld.  Androgenetic alopecia: an autosomal dominant disorder. , 1995, The American journal of medicine.

[14]  H. Uno,et al.  The effects of finasteride (Proscar) on hair growth, hair cycle stage, and serum testosterone and dihydrotestosterone in adult male and female stumptail macaques (Macaca arctoides). , 1994, The Journal of clinical endocrinology and metabolism.

[15]  N. Sadick,et al.  The effect of finasteride, a 5 alpha-reductase inhibitor, on scalp skin testosterone and dihydrotestosterone concentrations in patients with male pattern baldness. , 1994, The Journal of clinical endocrinology and metabolism.

[16]  M. New,et al.  Effect of finasteride on adrenal steroidogenesis in men. , 1994, Journal of andrology.

[17]  N. Stern,et al.  Effect of 5-alpha-reductase inhibition on sex-hormone-binding globulin in elderly men. , 1994, Hormone research.

[18]  J. Oesterling,et al.  Effect of finasteride on serum PSA concentration in men with benign prostatic hyperplasia. Results from the North American phase III clinical trial. , 1993, The Urologic clinics of North America.

[19]  M. Stiller,et al.  STATUS OF MEDICAL TREATMENT FOR ANDROGENETIC ALOPECIA , 1993, International journal of dermatology.

[20]  D. Russell,et al.  Tissue distribution and ontogeny of steroid 5 alpha-reductase isozyme expression. , 1993, The Journal of clinical investigation.

[21]  D. Peters,et al.  Finasteride , 1993, Drugs.

[22]  R. Busch,et al.  Azasteroids as inhibitors of testosterone 5α-reductase in mammalian skin , 1993, The Journal of Steroid Biochemistry and Molecular Biology.

[23]  Y. Weisman,et al.  Prolonged treatment with finasteride (a 5α‐reductase inhibitor) does not affect bone density and metabolism , 1992, Clinical endocrinology.

[24]  Z. Braf,et al.  Effects of long term treatment with finasteride (MK-906), a 5-alpha reductase inhibitor, on circulating LH, FSH, prolactin and estradiol. , 1992, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[25]  R. Rittmaster,et al.  Effect of finasteride, a 5 alpha-reductase inhibitor, on serum gonadotropins in normal men. , 1992, The Journal of clinical endocrinology and metabolism.

[26]  P. Höglund,et al.  Disposition and pharmacokinetics of [14C]finasteride after oral administration in humans. , 1992, Drug metabolism and disposition: the biological fate of chemicals.

[27]  M. Brunden,et al.  Hair growth effects of oral administration of finasteride, a steroid 5 alpha-reductase inhibitor, alone and in combination with topical minoxidil in the balding stumptail macaque. , 1992, The Journal of clinical endocrinology and metabolism.

[28]  D. Russell,et al.  Genetic and pharmacological evidence for more than one human steroid 5 alpha-reductase. , 1992, The Journal of clinical investigation.

[29]  D. Russell,et al.  Deletion of steroid 5α-reductase 2 gene in male pseudohermaphroditism , 1991, Nature.

[30]  E. Stoner.  The clinical development of a 5α-reductase inhibitor, finasteride , 1990, The Journal of Steroid Biochemistry and Molecular Biology.

[31]  J. James,et al.  The Biological Effects of a Pulsed Electrostatic Field with Specific Reference to Hair Electrotrichogenesis , 1990, International journal of dermatology.

[32]  D. Thompson,et al.  Effects of finasteride (MK-906), a 5 alpha-reductase inhibitor, on circulating androgens in male volunteers. , 1990, The Journal of clinical endocrinology and metabolism.

[33]  T. Yahata,et al.  A New Apparatus for Hair Regrowth in Male‐pattern Baldness , 1990, The Journal of dermatology.

[34]  O. Norwood,et al.  Male Pattern Baldness: classification and Incidence , 1975, Southern medical journal.

[35]  R. E. Peterson,et al.  Steroid 5alpha-reductase deficiency in man: an inherited form of male pseudohermaphroditism. , 1975, Science.

[36]  R. E. Peterson,et al.  Steroid 5α-Reductase Deficiency in Man: An Inherited Form of Male Pseudohermaphroditism , 1974, Science.